You are here

Home

NOTICE OF EXTRAORDINARY GENERAL MEETING

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES.

Reference is made to NorDiag ASA's ("NorDiag" or the "Company") stock exchange announcement on 26 March 2012, regarding the notice of the Extraordinary General Meeting on 16 April 2012, to resolve on, inter alia, the issuance of shares and warrants, and an authority for the Board of Directors to issue shares, as well as approval of a potential asset sale of the Company's business.

The Board of Directors of the Company has decided to call for a separate Extraordinary General Meeting to be held 23 April 2012 to resolve on the potential asset sale of the Company's business. The proposal implies that the approval of the asset sale will not be dealt with at the General Meeting on 16 April 2012, and, accordingly, item 8 in the notice dated 26 March 2012 is withdrawn and postponed until the General Meeting on 23 April 2012. The Board of Directors intends to provide further details of a potential asset sale at or prior to this General Meeting.

The notice of the Extraordinary General Meeting, as well as form of notice of attendance/ power of attorney, is attached.

For further information, please contact
CEO Mårten Wigstøl, Phone: +47 911 65775

About NorDiag:
NorDiag is a biotechnology company developing, manufacturing and marketing automated solutions (instruments and reagents) for sample preparation of DNA from difficult biological samples. DNA diagnostics give more rapid and precise answers, and are the fastest growing field within diagnostics. The Company's sample preparation solutions are today used in connection with STI, tuberculosis, MRSA, respiratory pathogens and viruses on instruments for large and small laboratories. NorDiag was founded in 2003 and has its headquarters in Oslo, Norway. The Company has offices and laboratories in Stockholm, Sweden and in Atlanta (GA), USA. The group has today 29.15 man-labour years. NorDiag is listed on the Oslo Stock Exchange with ticker NORD.

Notice of EGM

Read the notice in Norwegian here.